Join Us in the Fight Against C. difficile Colitis

LPOXY Therapeutics is considering launching an equity crowdfunding opportunity on Republic.com. We're on a mission to prevent the life-threatening condition known as C. difficile colitis, and we need your help.

Interested? Simply visit our page on Republic to express your interest. Don’t worry, signing up is just to show your support—there's no obligation to invest anything now, and you don’t need to specify any investment amount.

Why It Matters: In the past decade, nearly 5 million Americans have battled this severe infection. C. difficile colitis has touched the lives of 15 million Americans through immediate family, and 50 million through extended family. This isn't just a health issue; it's a crisis that the Centers for Disease Control and Prevention (CDC) has labeled an urgent public health threat.

Investing with Us: If we move forward based on your interest, we'll contact you with all the details when we’re ready to launch. We plan to use a Simple Agreement for Future Equity (SAFE) for this funding round. Not sure what a SAFE is? Learn more about SAFE investments through this Investopedia link. For an early look at our offer, check out our preliminary deal sheet here.

Together, we can make a significant impact. Join us in our mission to save lives and stop the spread of this dangerous infection.